111 related articles for article (PubMed ID: 26050357)
21. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
22. Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Cα in epithelial ovarian cancer.
Qi H; Sun B; Zhao X; Du J; Gu Q; Liu Y; Cheng R; Dong X
Oncol Rep; 2014 Aug; 32(2):771-9. PubMed ID: 24898696
[TBL] [Abstract][Full Text] [Related]
23. Cyclin A correlates with YB1, progression and resistance to chemotherapy in human epithelial ovarian cancer.
Cybulski M; Jarosz B; Nowakowski A; Jeleniewicz W; Kutarska E; Bednarek W; Stepulak A
Anticancer Res; 2015 Mar; 35(3):1715-21. PubMed ID: 25750333
[TBL] [Abstract][Full Text] [Related]
24. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).
Shuang T; Wang M; Zhou Y; Shi C
Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143
[TBL] [Abstract][Full Text] [Related]
25. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
[TBL] [Abstract][Full Text] [Related]
26. P-glycoprotein as a prognostic indicator in pre- and postchemotherapy ovarian adenocarcinoma.
Khalifa MA; Abdoh AA; Mannel RS; Walker JL; Angros LH; Min KW
Int J Gynecol Pathol; 1997 Jan; 16(1):69-75. PubMed ID: 8986535
[TBL] [Abstract][Full Text] [Related]
27. [Value of CA(125) in the prediction of optimal interval debulking surgery and its prognosis in patients with epithelial ovarian cancer].
Mu T; Li XP; Wang JL; Wang SJ; Wang Y; Sun XL; Cui H; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):566-70. PubMed ID: 23141174
[TBL] [Abstract][Full Text] [Related]
28. [Proteins of resistance and drug resistance in ovarian carcinoma patients].
Sedláková I; Laco J; Tošner J; Caltová K; Cervinka M; Rezáč A; Spaček J; Skapinec P
Klin Onkol; 2012; 25(6):457-63. PubMed ID: 23301649
[TBL] [Abstract][Full Text] [Related]
29. Expression of p53, p27 and Jab1 protein in epithelial ovarian tumors.
Lee WS; Park ES; Kim DH; Kim TH; Lee HH; Chung SH
Eur J Gynaecol Oncol; 2012; 33(4):358-62. PubMed ID: 23091890
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer.
Zhou S; Tang L; Wang H; Dai J; Zhang J; Shen L; Ng SW; Berkowitz RS
Gynecol Oncol; 2013 Oct; 131(1):69-76. PubMed ID: 23820113
[TBL] [Abstract][Full Text] [Related]
31. [Value of P-glycoprotein and glutathione S-transferase-pi as chemo-resistant indicators in ovarian cancers].
Zhang F; Qi L; Chen H
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):313-6. PubMed ID: 11783115
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase C isoforms α, δ and ε are differentially expressed in mouse ovaries at different stages of postnatal development.
Tepekoy F; Ustunel I; Akkoyunlu G
J Ovarian Res; 2014 Dec; 7():117. PubMed ID: 25491605
[TBL] [Abstract][Full Text] [Related]
33. Syndecan-1 serves as a marker for the progression of epithelial ovarian carcinoma.
Guo Q; Yang X; Ma Y; Ma L
Eur J Gynaecol Oncol; 2015; 36(5):506-13. PubMed ID: 26513873
[TBL] [Abstract][Full Text] [Related]
34. Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
Martín de la Fuente L; Malander S; Hartman L; Jönsson JM; Ebbesson A; Nilbert M; Måsbäck A; Hedenfalk I
Int J Gynecol Pathol; 2018 Mar; 37(2):101-109. PubMed ID: 28481779
[TBL] [Abstract][Full Text] [Related]
35. Increased cyclooxygenase-2 (COX-2) and P-glycoprotein-170 (MDR1) expression is associated with chemotherapy resistance and poor prognosis. Analysis in ovarian carcinoma patients with low and high survival.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Taddei GL
Int J Gynecol Cancer; 2005; 15(2):255-60. PubMed ID: 15823108
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study.
Elzarkaa AA; Sabaa BE; Abdelkhalik D; Mansour H; Melis M; Shaalan W; Farouk M; Malik E; Soliman AA
J Cancer Res Clin Oncol; 2016 May; 142(5):949-58. PubMed ID: 26762850
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer.
Du J; Li B; Fang Y; Liu Y; Wang Y; Li J; Zhou W; Wang X
BMC Cancer; 2015 Jul; 15():536. PubMed ID: 26198101
[TBL] [Abstract][Full Text] [Related]
38. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
[TBL] [Abstract][Full Text] [Related]
39. [The expression of MRP, GST-pi, Topo IIalpha and COX-2 in epithelial ovarian cancer and its relationship to drug resistance and prognosis].
Cao DY; Shen K; Yang JX; Guan J
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1738-41. PubMed ID: 17919376
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]